Lensar (LNSR) FCF Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,566.00 |
| Dec 31, 2025 | 3,140.00 |
| Sep 30, 2025 | 1,375.00 |
| Jun 30, 2025 | 775.00 |
| Mar 31, 2025 | -7,370.00 |
| Dec 31, 2024 | 151.00 |
| Sep 30, 2024 | 5,875.00 |
| Jun 30, 2024 | 183,094.00 |
| Mar 31, 2024 | -186,155.00 |
| Dec 31, 2023 | -152.00 |
| Sep 30, 2023 | 1,587.00 |
| Jun 30, 2023 | 6,189.00 |
| Mar 31, 2023 | -3,392.00 |
| Dec 31, 2022 | 2,718.00 |
| Sep 30, 2022 | -3,223.00 |
| Jun 30, 2022 | -887.00 |
| Mar 31, 2022 | -2,734.00 |
| Dec 31, 2021 | 2,069.00 |
| Sep 30, 2021 | -490.00 |
| Jun 30, 2021 | 5,794.00 |
| Mar 31, 2021 | -6,033.00 |
| Dec 31, 2020 | -1,860.00 |
| Sep 30, 2020 | 10,866.00 |
| Jun 30, 2020 | -1.00 |
| Mar 31, 2020 | -5,064.00 |